logo
15:50 Feb 25

Divi's Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
6395.50
+140.00 (+2.24%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Divi's Laboratories Ltd. Financials

Divi's Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
6395.50
+140.00 (+2.24%)
15:50 Feb 25
Quality
image/svg+xml

75/100
High Financial Strength

Valuation
image/svg+xml

24/100
Expensive Valuation

Technical

54/100
Technically Neutral

Strength

7

Weakness

3

Opportunity

1

Threats

1

14.63 %

ROE %

12.93 %

ROA %

93.38

EPS

564.87

BVPS

23.40 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
6969.4 8959.83 7767.51 7845 9360
Operating Expenses +
4109.46 5077.89 5399.69 5640 6392
Raw Material
2402.75 3490.97 3030.69 3238 3821
Increase Decrease in Cost
-78.67 -523.83 23.03 -109 -96
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
825.76 946.16 975.02 1094 1243
Miscellaneous Expenses
970.24 1193.41 1415.61 1429 1424
Operating Profit
2859.94 3881.94 2367.82 2205 2968
Other Income
62.56 113.87 344.66 339 352
Depreciation
255.59 311.51 343.18 378 402
Interest
0.87 0.8 0.67 3 2
Profit before tax and exceptio..
2666.04 3683.5 2368.63 2163 2916
Exceptional Items
0 0 0 0 0
PBT
2666.04 3683.5 2368.63 2163 2916
Provision for Taxation
681.75 723.05 545.25 563 725
Net Profit
1984.29 2960.45 1823.38 1600 2191
NET Profit after MI
1984.29 2960.45 1823.38 1600 2191
EPS
74.75 111.52 68.69 60.27 82.53
Operating Profit Margin (%)
41.04 43.33 30.48 28.11 31.71
Net Profit Margin (%)
28.47 33.04 23.47 20.4 23.41

Divi's Laboratories Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 51.90 51.90 51.90 51.90 51.90 51.90
FII 20.10 19.40 19.70 18.00 18.00 17.20
Public 19.30 19.80 19.10 20.70 20.50 21.10
Others 8.70 8.90 9.30 9.40 9.60 9.80
Shareholder Shares Holding %
Research 360 logo
Download Our App On: